论文部分内容阅读
目的:研究分析宫缩乏力性产后出血患者采用米索前列醇联合缩宫素治疗的临床效果。方法:在该院自2013年1月至2014年1月妇产科收治的宫缩乏力性产后出血患者中选取本次研究样本,样本容量为53例,采用随机分组对照的方法将其分成治疗组和对照组,前者采用米索前列醇联合缩宫素治疗,后者采用单纯缩宫素治疗,比较两种方法临床效果和不良反应情况。结果:治疗组出血量明显少于对照组,治疗组临床总有效率显著高于对照组(96.29%vs76.92%,P<0.05),并且未增加不良反应发生情况。结论:结果表明,宫缩乏力性产后出血患者采用米索前列醇联合缩宫素治疗具有较好的临床治疗效果,还不会增加药物不良反应,这种方案值得临床应用。
Objective: To study the clinical effect of misoprostol combined with oxytocin in patients with uterine inertia postpartum hemorrhage. Methods: The study sample was selected from patients with uterine inertia admitted to obstetrics and gynecology from January 2013 to January 2014 in our hospital. The sample size was 53 and divided into treatment groups by randomized controlled group Group and control group, the former with misoprostol combined with oxytocin treatment, the latter with simple oxytocin treatment, the clinical efficacy and adverse reactions of the two methods were compared. Results: The bleeding volume of the treatment group was significantly less than that of the control group. The total effective rate of the treatment group was significantly higher than that of the control group (96.29% vs 76.92%, P <0.05), and did not increase the incidence of adverse reactions. Conclusion: The results show that patients with uterine inert postpartum hemorrhage using misoprostol combined with oxytocin treatment has a good clinical effect, but will not increase the adverse drug reactions, this program is worthy of clinical application.